Market Overview:
The global artificial insemination market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for assisted reproductive technologies (ART) and rising infertility rates across the globe. In addition, growing awareness about ART procedures and their benefits is also contributing to the growth of this market. The global artificial insemination market can be segmented on the basis of type, application, and region. On the basis of type, the market can be divided into intrauterine insemination (IUI), intracervical insemination (ICI), intravaginal insemination (IVI), and intratubal insemination (ITI). IUI is currently one of the most commonly used ART procedures across clinics worldwide owing to its low cost and high success rate. On account of its high success rate, IVF has emerged as a popular choice among couples who are unable to conceive through other methods such as IUI or ICI.
Product Definition:
Artificial insemination is the introduction of sperm into a woman's uterus or cervix for the purpose of achieving pregnancy. It is a fertility treatment used to overcome male infertility, female infertility, or both.
Intrauterine Insemination:
Intrauterine insemination (IUI) is a fertility treatment that involves placing a spermicide tablet inside the uterus. It is done to improve the chances of conceiving for women who are trying to become pregnant but have had problems doing so.
Intracervical Insemination:
Intracervical insemination is a procedure wherein the semen is directly inserted into the woman's uterus through the cervical opening. It has been used by women across different cultures and countries for generations to have a baby.
The procedure was considered too intimate.
Application Insights:
The fertility clinics and others segment dominated the market in 2017. This is attributed to the rising number of artificial insemination procedures being performed at a global level. Increasing awareness about infertility has led to an increase in demand for assisted reproductive technology, which includes IVF, ICSI and AAT. As per the World Health Organization (WHO), around 7.5 million babies are born every year due to natural conception but less than half of them are born through vaginal delivery owing to low-quality sperm count or poor quality semen specimens obtained from men undergoing treatment for infertility issues or cancer treatments at hospitals across the world including India and China.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to various factors such as high adoption of ART, presence of a large number of fertility clinics and IVF centers, rising awareness about available treatment options, and supportive government initiatives. For instance, in U.S., egg freezing is covered by health insurance through private employers or government programs like Medicaid/CHIP (Children’s Health Insurance Program). Thus it has a major impact on the overall cost-related factor for these treatments.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing infertility rates due to lifestyle changes.
Growth Factors:
- Increasing demand for livestock products: The global population is growing at a rapid pace and so is the demand for meat, eggs, and milk. This is driving the need for artificial insemination to improve livestock productivity.
- Rising awareness about animal breeding techniques: Farmers are becoming increasingly aware of the benefits of artificial insemination and are using it to improve their herds’ genetic quality.
- Technological advancements: The introduction of new technologies such as embryo transfer has helped boost the growth of the artificial insemination market.
- Growing popularity of organic farming: Organic farming is gaining popularity across the globe due to its many benefits such as improved soil health and reduced environmental impact. This is helping drive demand for artificially inseminated animals bred through organic methods.
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Insemination Market Research Report
By Type
Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination
By Application
Fertility Clinics and Others, Home
By Companies
Irvine Scientific, Rinovum Women’s Health, LLC, Pride Angel, Hi-Tech Solutions, Conceivex, Inc., TenderNeeds Fertility, Rocket Medical PLC, Kitazato
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Insemination Market Report Segments:
The global Artificial Insemination market is segmented on the basis of:
Types
Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Clinics and Others, Home
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Irvine Scientific
- Rinovum Women’s Health, LLC
- Pride Angel
- Hi-Tech Solutions
- Conceivex, Inc.
- TenderNeeds Fertility
- Rocket Medical PLC
- Kitazato
Highlights of The Artificial Insemination Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intrauterine Insemination
- Intracervical Insemination
- Intravaginal Insemination
- Intratubal Insemination
- By Application:
- Fertility Clinics and Others
- Home
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Insemination Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial insemination is a process by which sperm is introduced into the uterus of a woman to create a pregnancy.
Some of the major companies in the artificial insemination market are Irvine Scientific, Rinovum Women’s Health, LLC, Pride Angel, Hi-Tech Solutions, Conceivex, Inc., TenderNeeds Fertility, Rocket Medical PLC, Kitazato.
The artificial insemination market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Artificial Insemination Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Artificial Insemination Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Artificial Insemination Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Artificial Insemination Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Artificial Insemination Market Size & Forecast, 2020-2028 4.5.1 Artificial Insemination Market Size and Y-o-Y Growth 4.5.2 Artificial Insemination Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Intrauterine Insemination
5.2.2 Intracervical Insemination
5.2.3 Intravaginal Insemination
5.2.4 Intratubal Insemination
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Fertility Clinics and Others
6.2.2 Home
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Artificial Insemination Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Artificial Insemination Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Intrauterine Insemination
9.6.2 Intracervical Insemination
9.6.3 Intravaginal Insemination
9.6.4 Intratubal Insemination
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Fertility Clinics and Others
9.10.2 Home
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Intrauterine Insemination
10.6.2 Intracervical Insemination
10.6.3 Intravaginal Insemination
10.6.4 Intratubal Insemination
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Fertility Clinics and Others
10.10.2 Home
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Intrauterine Insemination
11.6.2 Intracervical Insemination
11.6.3 Intravaginal Insemination
11.6.4 Intratubal Insemination
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Fertility Clinics and Others
11.10.2 Home
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Intrauterine Insemination
12.6.2 Intracervical Insemination
12.6.3 Intravaginal Insemination
12.6.4 Intratubal Insemination
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Fertility Clinics and Others
12.10.2 Home
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Intrauterine Insemination
13.6.2 Intracervical Insemination
13.6.3 Intravaginal Insemination
13.6.4 Intratubal Insemination
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Fertility Clinics and Others
13.10.2 Home
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Artificial Insemination Market: Competitive Dashboard
14.2 Global Artificial Insemination Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Irvine Scientific
14.3.2 Rinovum Women’s Health, LLC
14.3.3 Pride Angel
14.3.4 Hi-Tech Solutions
14.3.5 Conceivex, Inc.
14.3.6 TenderNeeds Fertility
14.3.7 Rocket Medical PLC
14.3.8 Kitazato